“…Meanwhile, MET expression was also elevated in PDAC ( Figure S7C ) and the increased MET (c-Met) is positively correlated with Pol II S5-p level and SET level ( Figures 6F , 6G , S7D-S7G ), implying that up-regulation of oncogene MET is part of the hyper-transcription program prompted by SET. Moreover, we observed that MET high expression is correlated with short survival time of PDAC patients, indicating that MET over-expression contributed to the malignancy of PDAC ( Figures S7I and S7J ) in accordance with previous reports (Ebert et al, 1994; Kiehne et al, 1997; Lee et al, 2003; Qin et al, 2022; Yan et al, 2018). In conclusion, IHC study in the PDAC consecutive sections ( Figure 6H ) supported the hypothesis that over-expressed SET, supporting CDK9-induced Pol II CTD phosphorylation, prompts the hyper-transcription of growth-essential genes including the oncogene MET ( Figure 6I ).…”